Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Tocris Bioscience™ ZJ 43

Catalog No. 267510
Change view
Click to view available options
Quantity:
1 mg
10 mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
26-751-0 10 mg
26-751-R 1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
This item is not returnable. View return policy
Catalog No. 26-751-0 Supplier Tocris Bioscience™ Supplier No. 2675/10

Item Discontinued This item has been discontinued by the supplier. Please to view product availability in your area.

This item is not returnable. View return policy

Glutamate carboxypeptidase II and III (NAALADase, NAAG peptidase) inhibitor

ZJ 43 is a potent inhibitor of glutamate carboxypeptidase II and III (GCP II and III/NAAG peptidase/NAALADase) (Ki values are 0.8 and 23 nM respectively) that inhibits the hydrolysis of NAAG (IC50 = 2.4 nM) . Does not directly interact with NMDA or metabotropic glutamate receptors. Reduces neuronal degeneration in a rat model of traumatic brain injury (TBI) and reduces locomotor activity in the PCP-model of schizophrenia.

Specifications

Chemical Name or Material N-[[[(1 S)-1-Carboxy-3-methylbutyl]amino]carbonyl]-L-glutamic acid
CAS 723331-20-2
Quantity 10 mg
Solubility Soluble to 100mM in DMSO
Target Carboxypeptidase Inhibitors
Molecular Formula C12H20N2O7
Formula Weight Observed MW: 304.3
Purity 95%

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.